Advertisement
Articles| Volume 5, ISSUE 2, P148-155, 2002

Preimplantation genetic diagnosis for cancer predisposition

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Preimplantation genetic diagnosis (PGD) has recently been offered for couples with an inherited predisposition for late onset disorders. This paper presents the results of PGD for a group of couples at risk for producing children with cancer predisposition. Using a standard IVF procedure, oocytes or embryos were tested for different mutations predisposing to cancer, preselecting and transferring only mutation-free embryos back to the patients. The procedure was performed for patients with predisposition to familial adenomatous polyposis coli (FAP), Von Hippel-Lindau syndrome (VHL), retinoblastoma, Li-Fraumeni syndrome, determined by p53 tumour suppressor gene mutations, neurofibromatosis types I and II and familial posterior fossa brain tumour (hSNF5). Overall, 20 PGD cycles were performed for 10 couples, resulting in preselection and transfer of 40 mutation-free embryos, which resulted in five unaffected clinical pregnancies and four healthy children born by the present time. Despite the controversy of PGD use for late onset disorders, the data demonstrate the usefulness of this approach as the only acceptable option for at-risk couples to avoid the birth of children with an inherited predisposition to cancer, and to have a healthy child.

      Keywords

      References

        • Ao A
        • Wells D
        • Handyside A
        • et al.
        Preimplantation genetic diagnosis of inherited cancer: familial adenomatous polyposis coli.
        Journal of Assisted Reproduction and Genetics. 1998; 15: 140-144
        • Cram D
        Preimplantation genetic diagnosis for familial cancer.
        Reproductive BioMedicine Online. 2001; 3: 3-4
        • Gerris J
        • Van Royen E
        • De Neubourg D
        • et al.
        Impact of single embryo transfer on the overall and twin pregnancy rates of an IVF/ICSI programme.
        Reproductive BioMedicine Online. 2001; 2: 172-177
        • International Working Group on Preimplantation Genetics
        Preimplantation Genetic Diagnosis – Experience of Three Thousand Clinical Cycles. Report of the 11th Annual Meeting International Working Group on Preimlantation Genetics, in conjunction with 10th International Congress of Human Genetics, Vienna, May 15, 2001.
        Reproductive BioMedicine Online. 2001; 3: 49-53
      1. Online Mendelian Inheritance in Man (OMIM) 2001 Johns Hopkins University http://www.ncbi.nlm.nih.gov/Omim (for FAP [MIM 175100]; for VHL [MIM 331900]; for RB [180200]; for hSNF5 [601607].

        • Rechitsky S
        • Strom C
        • Verlinsky O
        • et al.
        Allele drop out in polar bodies and blastemeres.
        Journal of Assisted Reproduction and Genetics. 1998; 15: 2532-2557
        • Rechitsky S
        • Strom C
        • Verlinsky O
        • et al.
        Accuracy of preimplantation diagnosis of single-gene disorders by polar body analysis of oocytes.
        Journal of Assisted Reproduction and Genetics. 1999; 16: 192-198
        • Rechitsky S
        • Verlinsky O
        • Strom C
        • et al.
        Experience with single-cell PCR in preimplantation genetic diagnosis: how to avoid pitfalls.
        in: Hahn S Holzgreve W Fetal Cells in Maternal Blood. New Developments for a New Millennium. 11th Fetal Cell Workshop, Basel, Karger, Basel, Switzerland2000: 8-15
        • Simpson JL
        Celebrating preimplantation genetic diagnosis of p53 mutations in Li-Fraumeni syndrome.
        Reproductive BioMedicine Online. 2001; 3: 2-3
        • Taylor MD
        • Gokgoz N
        • Andrulis IL
        • et al.
        Familial posterior fossa brain tumors of infancy secondaty to germline mutation of the hSNF5 Gene.
        American Journal of Human Genetics. 2000; 66: 1403-1406
        • Verlinsky Y
        • Kuliev A
        Atlas of Preimplantation Genetic Diagnosis. Parthenon, New York, London2000
        • Verlinsky Y
        • Rechitsky S
        • Verlinsky O
        • et al.
        Preimplantation diagnosis for p53 tumor suppressor gene mutations.
        Reproductive BioMedicine Online. 2001; 2: 102-105
        • Verlinsky Y
        • Rechitsky S
        • Verlinsky O
        • et al.
        Preimplantation diagnosis for neurofibromatosis.
        Reproductive BioMedicine Online. 2002; 4: 218-222

      Biography

      Dr Svetlana Rechitsky is a graduate of Kharkov University's Genetics Faculty, and received her PhD in Experimental Molecular Embryology from the Second Moscow Medical Institute in 1986. She moved to the Reproductive Genetics Institute in 1989 to head the DNA laboratory, which has performed the largest preimplantation genetic diagnosis (PGD) series for single gene disorders, with PGD design for the majority of these disorders developed for the first time. She has published more than 30 papers in the field of PGD, including a key contribution to the recently published Atlas of Preimplantation Genetic Diagnosis.